impact factor
logo
 

Review

 

Fibromyalgia position paper


1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27

 

  1. Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan, and University School of Medicine, Milan, Italy.
  2. Rheumatology Unit, Internal Medicine Department, ASST Fatebenefratelli-Sacco, Milan, and University School of Medicine, Milan, Italy. vale.gio@fastwebnet.it
  3. Rheumatology Unit, Department of Internal Medicine, University of Messina, Italy.
  4. Unit of Rheumatology and Clinical Immunology, ASST Spedali Civili, Brescia, Italy.
  5. Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, and Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  6. Section of Rheumatology, School of Medicine, Cardiff University, Cardiff, UK.
  7. Rheumatology Unit, AOU Pisana, Pisa, Italy.
  8. Department Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany.
  9. Department of Internal Medicine H, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  10. Institute of Rheumatology, Tel Aviv Sourasky Medical Centre and the Sackler Faculty of Medicine, Tel Aviv University, Israel.
  11. Ben Gurion University of the Negev, Beer Sheva, Israel.
  12. Department of Medicine B and Center of Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  13. Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, and Coimbra Institute for Clinical and Biomedical Research (i.CBR), Faculty of Medicine, University of Coimbra, Portugal.
  14. CETD, CHU Cochin, APHP, Paris-Descartes University, Inserm U987, Paris, France.
  15. Leuven Centre for Algology & Pain Management, University Hospitals Leuven, KU Leuven, Belgium.
  16. Department of Surgery, Odontostomatology and Maternal Sciences, Pain Therapy Centre, Verona University Hospital, Policlinico GB Rossi, Verona, Italy.
  17. Department of Surgery, Odontostomatology and Maternal Sciences, Pain Therapy Centre, Verona University Hospital, Policlinico GB Rossi, Verona, Italy.
  18. General Medical Clinic and Medical Therapy, Rheumatology and Medical Therapy of the Pain, University of Perugia, "Polo di Terni", "AO Santa Maria" of Terni, Italy.
  19. Paolo Procacci Foundation, Rome, Italy.
  20. Department of Clinical Internal Medicine, Anaesthesiological and Cardiovascular Sciences, Rheumatology Unit, Policlinico Umberto I, La Sapienza University of Rome, Italy.
  21. Clinical Psychology and Psycho-Oncology Unit, Department of Neuroscience, University of Turin, Azienda Ospedaliera Universitaria (A.O.U.) "Città della Salute e della Scienza" Hospital, Turin, Italy.
  22. ENFA Board Member and Unit of Rheumatology, Oslo University Hospital, Oslo, Norway.
  23. Institute of Neuroscience and Physiology, Section of Health and Rehabilitation, Physiotherapy, Sahlgrenska Academy, University of Gothenburg, Sweden.
  24. Rheumatology Clinic, Department of Clinical and Molecular Science, Università Politecnica delle Marche, Jesi, Ancona, Italy.
  25. Rheumatology Clinic, Department of Clinical and Molecular Science, Università Politecnica delle Marche, Jesi, Ancona, Italy.
  26. Departmental Unit of Rheumatology, Specialist Outpatients Department, ASL 1 Dolomiti, Belluno, Italy.
  27. Rheumatology Unit, Internal Medicine Department, ASST Settelaghi, Ospedale Di Circolo, Fondazione Macchi, Varese, Italy.

CER14563
2021 Vol.39, N°3 ,Suppl.130
PI 0186, PF 0193
Review

Free to view
(click on article PDF icon to read the article)

PMID: 34001303 [PubMed]

Received: 24/02/2021
Accepted : 15/04/2021
In Press: 13/05/2021
Published: 21/06/2021

Abstract

Fibromyalgia syndrome is one of the most common causes of chronic widespread pain, but pain accompanies a wide range of ancillary symptoms. To date, its aetiopathogenesis remains elusive, and diagnosis is exquisitely clinical, due to the lack of biomarkers or specific laboratory alterations in fibromyalgia patients. This position paper has the purpose to summarise the current scientific knowledge and expert opinions about the main controversies regarding fibromyalgia syndrome, namely: (i) fibromyalgia definition and why it is still not recognised in many countries as a distinct clinical entity; (ii) fibromyalgia severity and how to evaluate treatment outcome; (iii) how to treat fibromyalgia and which is a correct approach to fibromyalgia patients.

Rheumatology Article